Peptide therapies have become an increasingly discussed topic in the world of regenerative medicine and men’s health optimization. For many patients, peptides represent a new category of options that sits at the intersection of clinical science and personalized wellness.
Understanding what peptides are, how different compounds work, and what the current clinical picture looks like can help men approach these therapies with appropriate context and realistic expectations.
Peptides are short chains of amino acids — the same building blocks that make up proteins. The body naturally produces thousands of different peptides, each serving specific biological functions. Some act as hormones, others as signaling molecules, and others as regulators of immune function, tissue repair, or cellular communication.
In clinical and research settings, synthetic peptides have been developed that mimic or stimulate naturally occurring biological processes. When used therapeutically, these compounds are typically administered via subcutaneous injection or other routes, depending on the specific peptide and the clinical goal.
It is important to note that most peptides used in men’s health and wellness settings are compounded formulations and are not FDA-approved for the indications in which they are often discussed. Patients should have a thorough conversation with a licensed provider before considering any peptide therapy.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) — a naturally occurring hormone produced in the hypothalamus that stimulates the pituitary gland to release growth hormone (GH).
Rather than introducing exogenous growth hormone directly, sermorelin works by encouraging the body’s own pituitary gland to produce GH in a more physiologically regulated pattern. This distinction is considered clinically relevant by some providers, as it may support the body’s natural feedback mechanisms.
Sermorelin is FDA-approved for the treatment of growth hormone deficiency in children. Its use in adult men for wellness or anti-aging purposes is considered off-label. Related compounds, sometimes called growth hormone secretagogues (GHS), include ipamorelin and CJC-1295, among others. These compounds are compounded formulations and are not FDA-approved.
Some patients report improvements in sleep quality, body composition, and recovery when using growth hormone secretagogues, though clinical evidence in healthy adults is still developing, and individual responses vary.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. It has been studied primarily in animal models for its potential effects on tissue repair, inflammation modulation, and gut health.
Preclinical research has explored BPC-157’s potential role in supporting the healing of tendons, ligaments, muscle tissue, and the gastrointestinal tract. Some researchers have also investigated its effects on the nervous system and vascular function.
It is important to be clear about where the science currently stands: BPC-157 has not been approved by the FDA for any indication, and the clinical evidence in humans remains limited. Most available data comes from animal studies. Patients considering BPC-157 should discuss this honestly with a provider and understand that they would be using an unproven, compounded formulation.
PT-141, also known as bremelanotide, is a melanocortin receptor agonist that has been studied for its potential effects on sexual arousal and desire. It works through the central nervous system rather than through vascular pathways.
FDA-approved bremelanotide (marketed as Vyleesi) is approved for women with hypoactive sexual desire disorder (HSDD). Its use in men is off-label, and compounded PT-141 formulations used in men’s health settings are not FDA-approved.
Some men who have not responded adequately to conventional sexual wellness treatments have explored PT-141 under provider supervision. As with all compounded peptides, candidacy should be determined through a thorough medical evaluation.
Certain peptides have drawn interest for their potential role in metabolic function and body composition. AOD-9604, for example, is a modified fragment of human growth hormone that has been studied for its potential effects on fat metabolism.
These compounds are distinct from GLP-1 receptor agonists (such as semaglutide), which are FDA-approved medications with established clinical evidence. Compounded peptides used for metabolic support do not share the same regulatory or evidence status as FDA-approved medications.
For men considering peptide therapy, several points deserve careful consideration:
Regulatory status: Most peptides used in wellness settings are compounded formulations and are not FDA-approved. The quality, purity, and consistency of compounded products depends on the compounding pharmacy and the oversight of the prescribing provider.
Evidence base: The level of clinical evidence varies significantly between peptides. Some have more robust human data than others. Providers who are transparent about this distinction are offering patients honest, informed care.
Individual candidacy: Not every peptide is appropriate for every patient. A thorough medical evaluation — including a review of health history, current medications, and clinical goals — is necessary to determine whether any peptide therapy is appropriate.
Monitoring: As with any therapeutic intervention, monitoring for response and potential side effects is an important part of responsible care.
Peptide therapies represent a space where personalized, provider-led care is especially important. Given the evolving evidence base and the regulatory complexity of compounded formulations, patients benefit significantly from working with providers who are knowledgeable, transparent, and focused on individualized outcomes rather than one-size-fits-all protocols.
If you are interested in exploring peptide therapies, a consultation with a provider who specializes in regenerative medicine and men’s health is the appropriate starting point.
Disclaimer: Treatment eligibility is determined by a licensed healthcare provider based on individual medical history and clinical evaluation. The information in this article is for educational purposes only and does not constitute medical advice. Individual results may vary. Compounded peptide formulations, including BPC-157, ipamorelin, CJC-1295, AOD-9604, and compounded PT-141, are not FDA-approved.
Are peptides the same as steroids?
No. Peptides and anabolic steroids are entirely different classes of compounds with different mechanisms of action, regulatory histories, and risk profiles. They should not be conflated.
Is sermorelin FDA-approved?
Sermorelin is FDA-approved for growth hormone deficiency in children. Its use in adult men for wellness purposes is considered off-label. Patients should discuss this distinction with their provider.
How are peptides typically administered?
Administration method varies by compound. Many peptides used in clinical settings are administered via subcutaneous injection. Some may be available in other forms depending on the specific compound and the compounding pharmacy.
Are there risks associated with peptide therapy?
Like any therapeutic intervention, peptide therapies carry potential risks, which vary by compound and individual patient. Side effects, drug interactions, and contraindications should be discussed thoroughly with a provider before initiating any peptide therapy.
How do I know which peptide, if any, is right for me?
This is a clinical question best answered by a provider who specializes in regenerative medicine and men’s health. A thorough evaluation of your health history, symptoms, labs, and goals is the appropriate foundation for any treatment discussion.
